Q5YP69 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeif36atvradtx373qi7o2klqacsrt6ldfq4avujx7mva6kp4a6mn7y/metadata.json
IPFS of structure file: 
bafybeicgz4g5gsvy7ccfx72sldaoxwtxks2n2krvjlkr7bits2oivdc7hi/AF-Q5YP69-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x3103931037B3C500a07b6CD5CC2934Cfc0d5Caa7
First NFT owner address (bech32): 
genesis1xypexyphk0zspgrmdn2uc2f5elqdtj48ekg7lf
Current NFT ID #166762 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166762
Accession (UniProt):
Q5YP69
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
NOCARDIA FARCINICA (STRAIN IFM 10152)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q5YP69 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q5YP69|HEM1_NOCFA Glutamyl-tRNA reductase OS=Nocardia farcinica (strain IFM 10152) OX=247156 GN=hemA PE=3 SV=1 MSVLLVGVSHRSAPVSVLEKVAITDADRPKLIDKMLASSHISEAMIVSTCNRVEVYAVVDAFHGGLAEVGELLTRHSGLAMPDLTKHAYVRYSEAAAEHLFAVASGLDSMVVGEQQVLSQIRGAYATADAQQAVGRTLHELAQHALRVGKRVHSETGIDRAGASVVSVALDRAAQVLGDLAGRTAVVVGAGAMGGLSVAHLARAGIGRIIVVNRTIERARRLAETAASYGVESSALELDRLHEAMSAADVVLSCTGAVGAVVTLADTHRALADRDRAEFPAGDRPLVFCDLGLPRDVEPAVAGLPGVAVIDIESLQRDPAAGAAADDTAAARSIVAEELAKYLAGQRMAEVTPTVAALRQRAAEVVEAELLRLDSRLPGLAEPERDEVARTVRRVVDKLLHAPTVRVKQLASTPGGDSYAEALRELFELKPGAAQAVAAPMEITAIGPDRTAGLADDFTPGHRLDFEQHLGEEGKPA